Výsledky vyhledávání - "Cambridge Prognostic Groups"

Akademický článek

The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Autor: V. J. Gnanapragasam, O. Bratt, K. Muir, L. S. Lee, H. H. Huang, P. Stattin, A. Lophatananon

Publikováno v: BMC Medicine, Vol 16, Iss 1, Pp 1-10 (2018)

Abstract Background The purpose of this study is to validate a new five-tiered prognostic classification system to better discriminate cancer-specific mortality in men diagnosed with primary non-metastatic prostate cancer. Methods We applied a recent

Externí odkaz: https://doaj.org/article/3754ccf9581d4b09ac4a258ad3deb88a

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Additional file 3: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Autor: V. Gnanapragasam, O. Bratt, K. Muir, L. Lee, H. Huang, P. Stattin, A. Lophatananon

Table S3. Concordance indices of the current three-strata risk group model (NICE) and Cambridge Prognostic Group (CPG) from competing risk analysis in predicting prostate cancer-specific mortality stratified by age groups in the PCBaSe cohort (p < 0.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1d92bfbe2135952cb65c49a83a3a172

Zobrazit plný text záznamu

Additional file 8: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Autor: V. Gnanapragasam, O. Bratt, K. Muir, L. Lee, H. Huang, P. Stattin, A. Lophatananon

Table S8. Competing risk regression analysis of the Cambridge Prognostic Group (CPG) by treatment type. A. Radical prostatectomy cohort (n = 20,586), B. radical radiotherapy cohort (n = 11,872) and C. conservative management cohort (n = 14,950). Inte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c890c6d0d97ef3f84f7fdbab0e50f90

Zobrazit plný text záznamu

Additional file 7: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Autor: V. Gnanapragasam, O. Bratt, K. Muir, L. Lee, H. Huang, P. Stattin, A. Lophatananon

Table S7. Distribution of cases and deaths from prostate cancer and hazard ratios for each Cambridge Prognostic Group (CPG) in the PCBaSe radical radiotherapy cohort (n = 11,872). (DOCX 15 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31c4b633f5d6ffe5f50698759d0ed3bd

Zobrazit plný text záznamu

Additional file 5: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Autor: V. Gnanapragasam, O. Bratt, K. Muir, L. Lee, H. Huang, P. Stattin, A. Lophatananon

Table S5. Distribution of cases/deaths and sub-hazard ratios from competing risk analysis for each Cambridge Prognostic Group (CPG) in the Singapore cohort (n = 2550). (DOCX 15 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28083ba470b884efec97394ec514d51c

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání